We found that plasma from SCLC patients hold a hypercoagulable profile with increased TG and FVIII activity, and a significantly decreased PPL clotting time, indicating a high PPL activity, compared to a group of healthy age-related controls. This evidence concerns the gene PPL and small cell lung carcinoma.